1st 0 3 0 3 O
complete 4 12 4 12 O
remission 13 22 13 22 O
, 22 23 22 23 O
but 24 27 24 27 O
very 28 32 28 32 O
high 33 37 33 37 O
- 37 38 37 38 O
risk 38 42 38 42 O
features 43 51 43 51 O
( 52 53 52 53 O
i.e. 53 57 53 57 O
, 57 58 57 58 O
< 59 60 59 60 O
20 61 63 61 63 B-upper_bound
% 63 64 63 64 I-upper_bound
survival 65 73 65 73 B-clinical_variable
with 74 78 74 78 O
conventional 79 91 79 91 B-treatment
therapy 92 99 92 99 I-treatment
) 99 100 99 100 O

ALT 0 3 101 104 B-clinical_variable
( 4 5 105 106 I-clinical_variable
alanine 5 12 106 113 I-clinical_variable
aminotransferase 13 29 114 130 I-clinical_variable
, 29 30 130 131 I-clinical_variable
SCPT 31 35 132 136 I-clinical_variable
) 35 36 136 137 I-clinical_variable
≤ 37 38 138 139 O
5 39 40 140 141 B-upper_bound
x 41 42 142 143 I-upper_bound
Upper 43 48 144 149 I-upper_bound
LImit 49 54 150 155 I-upper_bound
of 55 57 156 158 I-upper_bound
Normal 58 64 159 165 I-upper_bound
( 65 66 166 167 I-upper_bound
ULN 66 69 167 170 I-upper_bound
) 69 70 170 171 I-upper_bound
for 71 74 172 175 O
age 75 78 176 179 B-age

Donor 0 5 180 185 O
must 6 10 186 190 O
be 11 13 191 193 O
18 14 16 194 196 B-lower_bound
years 17 22 197 202 I-lower_bound
or 23 25 203 205 O
older 26 31 206 211 O

Ejection 0 8 212 220 B-clinical_variable
fraction 9 17 221 229 I-clinical_variable
of 18 20 230 232 O
> 21 22 233 234 O
40 23 25 235 237 B-lower_bound
% 25 26 237 238 I-lower_bound
by 27 29 239 241 O
Multigated 30 40 242 252 B-treatment
Acquisition 41 52 253 264 I-treatment
Scan 53 57 265 269 I-treatment
( 58 59 270 271 I-treatment
MUGA 59 63 271 275 I-treatment
) 63 64 275 276 I-treatment
or 65 67 277 279 O
echocardiogram 68 82 280 294 B-treatment

Enrollment 0 10 295 305 O
in 11 13 306 308 O
any 14 17 309 312 O
other 18 23 313 318 B-treatment
clinical 24 32 319 327 I-treatment
study 33 38 328 333 I-treatment
from 39 43 334 338 O
screening 44 53 339 348 O
up 54 56 349 351 O
to 57 59 352 354 O
Day 60 63 355 358 O
100 64 67 359 362 O

Failure 0 7 363 370 O
to 8 10 371 373 O
achieve 11 18 374 381 O
Complete 19 27 382 390 O
Response 28 36 391 399 O
( 37 38 400 401 O
CR 38 40 401 403 O
) 40 41 403 404 O
following 42 51 405 414 O
initial 52 59 415 422 O
therapy 60 67 423 430 B-treatment

Glomerular 0 10 431 441 B-clinical_variable
Filtration 11 21 442 452 I-clinical_variable
Rate 22 26 453 457 I-clinical_variable
( 27 28 458 459 I-clinical_variable
GFR 28 31 459 462 I-clinical_variable
) 31 32 462 463 I-clinical_variable
≥ 33 34 464 465 O
60 35 37 466 468 B-lower_bound
ml 38 40 469 471 I-lower_bound
/ 40 41 471 472 I-lower_bound
min/1.73m2 41 51 472 482 I-lower_bound

HIV 0 3 483 486 B-chronic_disease
1 4 5 487 488 I-chronic_disease
& 6 7 489 490 I-chronic_disease
2 8 9 491 492 I-chronic_disease
antibody 10 18 493 501 O
( 19 20 502 503 O
Anti 20 24 503 507 O
- 24 25 507 508 O
HIV-1 25 30 508 513 B-chronic_disease
, 30 31 513 514 O
2 32 33 515 516 O
plus 34 38 517 521 O
O 39 40 522 523 O
) 40 41 523 524 O

HIV 0 3 525 528 B-chronic_disease
infection 4 13 529 538 O

HTLV 0 4 539 543 O
I 5 6 544 545 B-lower_bound
/ 6 7 545 546 O
II 7 9 546 548 B-upper_bound
antibody 10 18 549 557 O
( 19 20 558 559 O
Anti 20 24 559 563 O
- 24 25 563 564 O
HTLV 25 29 564 568 O
I 30 31 569 570 O
/ 31 32 570 571 O
II 32 34 571 573 O
) 34 35 573 574 O

Haploidentical 0 14 575 589 B-treatment
by 15 17 590 592 O
HLA 18 21 593 596 O
- 21 22 596 597 O
typing 22 28 597 603 O

Heart 0 5 604 609 B-chronic_disease
failure 6 13 610 617 I-chronic_disease

Hematologic 0 11 618 629 B-cancer
malignancy 12 22 630 640 I-cancer
or 23 25 641 643 O
solid 26 31 644 649 B-cancer
tumor 32 37 650 655 I-cancer

Hepatitis 0 9 656 665 B-treatment
B 10 11 666 667 I-treatment
core 12 16 668 672 I-treatment
antibody 17 25 673 681 I-treatment
( 26 27 682 683 I-treatment
Anti 27 31 683 687 I-treatment
- 31 32 687 688 I-treatment
HBc 32 35 688 691 I-treatment
) 35 36 691 692 I-treatment

Hepatitis 0 9 693 702 B-chronic_disease
B 10 11 703 704 I-chronic_disease
surface 12 19 705 712 O
antigen 20 27 713 720 O
( 28 29 721 722 O
HBsAg 29 34 722 727 O
) 34 35 727 728 O

Hepatitis 0 9 729 738 B-chronic_disease
C 10 11 739 740 I-chronic_disease
antibody 12 20 741 749 O
( 21 22 750 751 O
Anti 22 26 751 755 O
- 26 27 755 756 O
HCV 27 30 756 759 O
) 30 31 759 760 O

High 0 4 761 765 O
- 4 5 765 766 O
risk 5 9 766 770 O
refractory 10 20 771 781 O
or 21 23 782 784 O
relapsed 24 32 785 793 O
ALL 33 36 794 797 O
in 37 39 798 800 O
patients 40 48 801 809 O
for 49 52 810 813 O
whom 53 57 814 818 O
transplantation 58 73 819 834 B-treatment
is 74 76 835 837 O
deemed 77 83 838 844 O
indicated 84 93 845 854 O
( 94 95 855 856 O
relapse 95 102 856 863 O
occurring 103 112 864 873 O
< 113 114 874 875 O
30 115 117 876 878 B-upper_bound
months 118 124 879 885 I-upper_bound
from 125 129 886 890 O
diagnosis 130 139 891 900 O
, 139 140 900 901 O
patients 141 149 902 910 O
relapsing 150 159 911 920 O
after 160 165 921 926 O
previous 166 174 927 935 B-treatment
allogeneic 175 185 936 946 I-treatment
transplant 186 196 947 957 I-treatment
, 196 197 957 958 O
relapse 198 205 959 966 B-treatment
after 206 211 967 972 I-treatment
2nd 212 215 973 976 I-treatment
remission 216 225 977 986 I-treatment
, 225 226 986 987 O
primary 227 234 988 995 O
induction 235 244 996 1005 O
failure 245 252 1006 1013 O
or 253 255 1014 1016 O
hypodiploidy 256 268 1017 1029 B-cancer
) 268 269 1029 1030 O

Hodgkin 0 7 1031 1038 B-cancer
lymphoma 8 16 1039 1047 I-cancer
relapsing 17 26 1048 1057 O
after 27 32 1058 1063 O
auto 33 37 1064 1068 B-treatment
- 37 38 1068 1069 I-treatment
HSCT 38 42 1069 1073 I-treatment

If 0 2 1074 1076 O
measured 3 11 1077 1085 O
, 11 12 1085 1086 O
carbon 13 19 1087 1093 O
monoxide 20 28 1094 1102 O
diffusion 29 38 1103 1112 O
capacity 39 47 1113 1121 O
( 48 49 1122 1123 O
DLCO 49 53 1123 1127 B-clinical_variable
) 53 54 1127 1128 O
> 55 56 1129 1130 O
50 56 58 1130 1132 B-lower_bound
% 58 59 1132 1133 I-lower_bound

If 0 2 1134 1136 O
of 3 5 1137 1139 O
reproductive 6 18 1140 1152 O
potential 19 28 1153 1162 O
, 28 29 1162 1163 O
negative 30 38 1164 1172 B-pregnancy
pregnancy 39 48 1173 1182 I-pregnancy
test 49 53 1183 1187 O
and 54 57 1188 1191 O
willing 58 65 1192 1199 O
to 66 68 1200 1202 O
use 69 72 1203 1206 O
effective 73 82 1207 1216 O
birth 83 88 1217 1222 O
control 89 96 1223 1230 O
method 97 103 1231 1237 O

Is 0 2 1238 1240 O
free 3 7 1241 1245 O
from 8 12 1246 1250 O
communicable 13 25 1251 1263 O
disease 26 33 1264 1271 O
risks 34 39 1272 1277 O
associated 40 50 1278 1288 O
with 51 55 1289 1293 O
xenotransplantation 56 75 1294 1313 B-treatment

Is 0 2 1314 1316 O
free 3 7 1317 1321 O
from 8 12 1322 1326 O
risk 13 17 1327 1331 O
factors 18 25 1332 1339 O
for 26 29 1340 1343 O
, 29 30 1343 1344 O
and 31 34 1345 1348 O
clinical 35 43 1349 1357 O
evidence 44 52 1358 1366 O
of 53 55 1367 1369 O
, 55 56 1369 1370 O
infection 57 66 1371 1380 O
due 67 70 1381 1384 O
to 71 73 1385 1387 O
relevant 74 82 1388 1396 O
communicable 83 95 1397 1409 B-chronic_disease
disease 96 103 1410 1417 I-chronic_disease
agents 104 110 1418 1424 O
and 111 114 1425 1428 O
diseases 115 123 1429 1437 O

Lactating 0 9 1438 1447 O
females 10 17 1448 1455 B-gender

Life 0 4 1456 1460 B-clinical_variable
expectancy 5 15 1461 1471 I-clinical_variable
of 16 18 1472 1474 O
≥ 19 20 1475 1476 O
3 21 22 1477 1478 B-lower_bound
months 23 29 1479 1485 I-lower_bound

MPX 0 3 1486 1489 O
for 4 7 1490 1493 O
: 7 8 1493 1494 O
HepB 9 13 1495 1499 B-chronic_disease
( 14 15 1500 1501 O
HBV 15 18 1501 1504 O
- 18 19 1504 1505 O
PCR 19 22 1505 1508 O
) 22 23 1508 1509 O
, 23 24 1509 1510 O
HepC 25 29 1511 1515 B-chronic_disease
( 30 31 1516 1517 O
HCV 31 34 1517 1520 O
- 34 35 1520 1521 O
PCR 35 38 1521 1524 O
) 38 39 1524 1525 O
, 39 40 1525 1526 O
HIV 41 44 1527 1530 B-chronic_disease
( 45 46 1531 1532 O
HIV 46 49 1532 1535 O
- 49 50 1535 1536 O
PCR 50 53 1536 1539 O
) 53 54 1539 1540 O

Myelodysplastic 0 15 1541 1556 B-cancer
Syndrome 16 24 1557 1565 I-cancer
/ 24 25 1565 1566 O
Myeloproliferative 25 43 1566 1584 B-cancer
Syndrome 44 52 1585 1593 I-cancer

NAT 0 3 1594 1597 B-treatment
for 4 7 1598 1601 O
West 8 12 1602 1606 B-chronic_disease
Nile 13 17 1607 1611 I-chronic_disease
Virus 18 23 1612 1617 I-chronic_disease
( 24 25 1618 1619 O
WNV 25 28 1619 1622 B-treatment
- 28 29 1622 1623 I-treatment
PCR 29 32 1623 1626 I-treatment
) 32 33 1626 1627 O

Negative 0 8 1628 1636 O
testing 9 16 1637 1644 O
for 17 20 1645 1648 O
relevant 21 29 1649 1657 O
communicable 30 42 1658 1670 B-chronic_disease
diseases 43 51 1671 1679 I-chronic_disease

Neuroblastoma 0 13 1680 1693 B-cancer

No 0 2 1694 1696 O
evidence 3 11 1697 1705 O
of 12 14 1706 1708 O
dyspnea 15 22 1709 1716 B-chronic_disease
at 23 25 1717 1719 O
rest 26 30 1720 1724 O

No 0 2 1725 1727 O
severe 3 9 1728 1734 O
peripheral 10 20 1735 1745 B-chronic_disease
neuropathy 21 31 1746 1756 I-chronic_disease

No 0 2 1757 1759 O
supplemental 3 15 1760 1772 B-treatment
oxygen 16 22 1773 1779 I-treatment
requirement 23 34 1780 1791 O

Non 0 3 1792 1795 B-cancer
- 3 4 1795 1796 I-cancer
Hodgkin 4 11 1796 1803 I-cancer
lymphoma 12 20 1804 1812 I-cancer
relapsing 21 30 1813 1822 O
after 31 36 1823 1828 B-treatment
auto 37 41 1829 1833 I-treatment
- 41 42 1833 1834 I-treatment
HSCT 42 46 1834 1838 I-treatment

Osteosarcoma 0 12 1839 1851 B-cancer

Patient 0 7 1852 1859 O
must 8 12 1860 1864 O
have 13 17 1865 1869 O
fully 18 23 1870 1875 O
recovered 24 33 1876 1885 O
from 34 38 1886 1890 O
acute 39 44 1891 1896 O
toxic 45 50 1897 1902 O
effects 51 58 1903 1910 O
of 59 61 1911 1913 O
all 62 65 1914 1917 O
prior 66 71 1918 1923 B-treatment
chemotherapy 72 84 1924 1936 I-treatment
, 84 85 1936 1937 O
immunotherapy 86 99 1938 1951 B-treatment
, 99 100 1951 1952 O
or 101 103 1953 1955 O
radiotherapy 104 116 1956 1968 B-treatment
prior 117 122 1969 1974 O
to 123 125 1975 1977 O
entering 126 134 1978 1986 O
this 135 139 1987 1991 O
study 140 145 1992 1997 O

Patients 0 8 1998 2006 O
with 9 13 2007 2011 O
hematologic 14 25 2012 2023 B-cancer
malignancy 26 36 2024 2034 I-cancer
must 37 41 2035 2039 O
have 42 46 2040 2044 O
no 47 49 2045 2047 O
HLA 50 53 2048 2051 B-cancer
identical 54 63 2052 2061 O
sibling 64 71 2062 2069 O
or 72 74 2070 2072 O
suitable 75 83 2073 2081 O
unrelated 84 93 2082 2091 O
donor 94 99 2092 2097 O
OR 100 102 2098 2100 O
time 103 107 2101 2105 O
needed 108 114 2106 2112 O
to 115 117 2113 2115 O
find 118 122 2116 2120 O
an 123 125 2121 2123 O
acceptable 126 136 2124 2134 O
unrelated 137 146 2135 2144 O
donor 147 152 2145 2150 O
match 153 158 2151 2156 O

Patients 0 8 2157 2165 O
with 9 13 2166 2170 O
more 14 18 2171 2175 O
than 19 23 2176 2180 O
one 24 27 2181 2184 B-lower_bound
malignancy 28 38 2185 2195 B-cancer
( 39 40 2196 2197 O
hematologic 40 51 2197 2208 B-chronic_disease
or 52 54 2209 2211 O
solid 55 60 2212 2217 B-cancer
tumor 61 66 2218 2223 I-cancer
) 66 67 2223 2224 O

Patients 0 8 2225 2233 O
with 9 13 2234 2238 O
seizure 14 21 2239 2246 B-chronic_disease
disorders 22 31 2247 2256 I-chronic_disease
may 32 35 2257 2260 O
be 36 38 2261 2263 O
enrolled 39 47 2264 2272 O
if 48 50 2273 2275 O
seizures 51 59 2276 2284 B-chronic_disease
are 60 63 2285 2288 O
well 64 68 2289 2293 O
controlled 69 79 2294 2304 O
on 80 82 2305 2307 O
anticonvulsant 83 97 2308 2322 B-treatment
therapy 98 105 2323 2330 I-treatment

Patients 0 8 2331 2339 O
with 9 13 2340 2344 O
solid 14 19 2345 2350 B-cancer
tumor 20 25 2351 2356 I-cancer
must 26 30 2357 2361 O
have 31 35 2362 2366 O
failed 36 42 2367 2373 O
or 43 45 2374 2376 O
have 46 50 2377 2381 O
been 51 55 2382 2386 O
ineligible 56 66 2387 2397 O
to 67 69 2398 2400 O
receive 70 77 2401 2408 O
auto 78 82 2409 2413 B-treatment
- 82 83 2413 2414 I-treatment
HSCT 83 87 2414 2418 I-treatment
or 88 90 2419 2421 O
if 91 93 2422 2424 O
auto 94 98 2425 2429 O
- 98 99 2429 2430 O
HSCT 99 103 2430 2434 O
would 104 109 2435 2440 O
not 110 113 2441 2444 O
offer 114 119 2445 2450 O
> 120 121 2451 2452 O
20 122 124 2453 2455 B-lower_bound
% 124 125 2455 2456 I-lower_bound
chance 126 132 2457 2463 O
of 133 135 2464 2466 O
cure 136 140 2467 2471 O

Pregnant 0 8 2472 2480 B-pregnancy

Pregnant 0 8 2481 2489 B-pregnancy
females 9 16 2490 2497 B-gender

Primary 0 7 2498 2505 O
refractory 8 18 2506 2516 O
or 19 21 2517 2519 O
relapsed 22 30 2520 2528 O
non 31 34 2529 2532 B-cancer
- 34 35 2532 2533 I-cancer
Hodgkin 35 42 2533 2540 I-cancer
lymphoma 43 51 2541 2549 I-cancer
unable 52 58 2550 2556 O
to 59 61 2557 2559 O
achieve 62 69 2560 2567 O
2nd 70 73 2568 2571 O
remission 74 83 2572 2581 O
or 84 86 2582 2584 O
VGPR 87 91 2585 2589 O
and 92 95 2590 2593 O
therefore 96 105 2594 2603 O
ineligible 106 116 2604 2614 O
to 117 119 2615 2617 O
receive 120 127 2618 2625 O
auto 128 132 2626 2630 B-treatment
- 132 133 2630 2631 I-treatment
HSCT 133 137 2631 2635 I-treatment

Prior 0 5 2636 2641 B-treatment
organ 6 11 2642 2647 I-treatment
allograft 12 21 2648 2657 I-treatment

RPR 0 3 2658 2661 O
( 4 5 2662 2663 O
Syphilis 5 13 2663 2671 B-chronic_disease
TP 14 16 2672 2674 O
) 16 17 2674 2675 O

Relapsed 0 8 2676 2684 O
Hodgkin 9 16 2685 2692 B-cancer
lymphoma 17 25 2693 2701 I-cancer
unable 26 32 2702 2708 O
to 33 35 2709 2711 O
achieve 36 43 2712 2719 O
2nd 44 47 2720 2723 O
remission 48 57 2724 2733 O
or 58 60 2734 2736 O
Very 61 65 2737 2741 O
Good 66 70 2742 2746 O
Partial 71 78 2747 2754 O
Response 79 87 2755 2763 O
( 88 89 2764 2765 O
VGPR 89 93 2765 2769 O
) 93 94 2769 2770 O
and 95 98 2771 2774 O
therefore 99 108 2775 2784 O
ineligible 109 119 2785 2795 O
to 120 122 2796 2798 O
receive 123 130 2799 2806 O
autologous 131 141 2807 2817 B-treatment
hematopoietic 142 155 2818 2831 I-treatment
stem 156 160 2832 2836 I-treatment
cell 161 165 2837 2841 I-treatment
transplant 166 176 2842 2852 I-treatment
( 177 178 2853 2854 I-treatment
auto 178 182 2854 2858 I-treatment
- 182 183 2858 2859 I-treatment
HSCT 183 187 2859 2863 I-treatment
) 187 188 2863 2864 I-treatment

Relapsed 0 8 2865 2873 O
or 9 11 2874 2876 O
primary 12 19 2877 2884 B-cancer
refractory 20 30 2885 2895 I-cancer
metastatic 31 41 2896 2906 I-cancer

Relapsed 0 8 2907 2915 O
or 9 11 2916 2918 O
primary 12 19 2919 2926 B-treatment
therapy 20 27 2927 2934 I-treatment
- 27 28 2934 2935 O
refractory 28 38 2935 2945 O
AML 39 42 2946 2949 B-cancer
with 43 47 2950 2954 O
bone 48 52 2955 2959 B-clinical_variable
marrow 53 59 2960 2966 I-clinical_variable
blast 60 65 2967 2972 I-clinical_variable
< 66 67 2973 2974 O
20 68 70 2975 2977 B-upper_bound
% 70 71 2977 2978 I-upper_bound

Relapsed 0 8 2979 2987 O
with 9 13 2988 2992 O
pulmonary 14 23 2993 3002 B-cancer
or 24 26 3003 3005 O
bone 27 31 3006 3010 B-cancer
metastases 32 42 3011 3021 I-cancer
and 43 46 3022 3025 O
did 47 50 3026 3029 O
not 51 54 3030 3033 O
achieve 55 62 3034 3041 O
a 63 64 3042 3043 O
CR 65 67 3044 3046 O
with 68 72 3047 3051 O
surgery 73 80 3052 3059 B-treatment
and/or 81 87 3060 3066 O
chemotherapy 88 100 3067 3079 B-treatment

Significant 0 11 3080 3091 O
serious 12 19 3092 3099 O
intercurrent 20 32 3100 3112 B-chronic_disease
illness 33 40 3113 3120 I-chronic_disease
unrelated 41 50 3121 3130 O
to 51 53 3131 3133 O
cancer 54 60 3134 3140 B-cancer
or 61 63 3141 3143 O
its 64 67 3144 3147 O
treatment 68 77 3148 3157 B-treatment
not 78 81 3158 3161 O
covered 82 89 3162 3169 O
by 90 92 3170 3172 O
other 93 98 3173 3178 O
exclusion 99 108 3179 3188 O
criteria 109 117 3189 3197 O
expected 118 126 3198 3206 O
to 127 129 3207 3209 O
significantly 130 143 3210 3223 O
increase 144 152 3224 3232 O
the 153 156 3233 3236 O
risk 157 161 3237 3241 O
of 162 164 3242 3244 O
HSCT 165 169 3245 3249 B-clinical_variable

Soft 0 4 3250 3254 B-cancer
tissue 5 11 3255 3261 I-cancer
sarcomas 12 20 3262 3270 I-cancer
( 21 22 3271 3272 O
Rhabdomyosarcoma 22 38 3272 3288 B-cancer
, 38 39 3288 3289 O
Ewing 40 45 3290 3295 B-cancer
sarcoma 46 53 3296 3303 I-cancer
, 53 54 3303 3304 O
Primitive 55 64 3305 3314 B-cancer
Neuroectodermal 65 80 3315 3330 I-cancer
Tumor 81 86 3331 3336 I-cancer
or 87 89 3337 3339 O
other 90 95 3340 3345 O
high 96 100 3346 3350 O
- 100 101 3350 3351 O
risk 101 105 3351 3355 O
extracranial 106 118 3356 3368 B-cancer
solid 119 124 3369 3374 I-cancer
tumors 125 131 3375 3381 I-cancer
) 131 132 3381 3382 O

Study 0 5 3383 3388 O
enrollment 6 16 3389 3399 O
no 17 19 3400 3402 O
earlier 20 27 3403 3410 O
than 28 32 3411 3415 O
3 33 34 3416 3417 B-upper_bound
months 35 41 3418 3424 I-upper_bound
after 42 47 3425 3430 I-upper_bound
preceding 48 57 3431 3440 B-treatment
HSCT 58 62 3441 3445 I-treatment

T. 0 2 3446 3448 B-treatment
Cruzi 3 8 3449 3454 I-treatment
- 9 10 3455 3456 I-treatment
EIA 11 14 3457 3460 I-treatment
( 15 16 3461 3462 I-treatment
Chagas 16 22 3462 3468 I-treatment
) 22 23 3468 3469 I-treatment

Total 0 5 3470 3475 B-clinical_variable
bilirubin 6 15 3476 3485 I-clinical_variable
< 16 17 3486 3487 O
3 18 19 3488 3489 B-upper_bound
mg 20 22 3490 3492 I-upper_bound
/ 22 23 3492 3493 I-upper_bound
dL 23 25 3493 3495 I-upper_bound

Uncontrolled 0 12 3496 3508 B-chronic_disease
, 12 13 3508 3509 O
Serious 14 21 3510 3517 O
Active 22 28 3518 3524 B-chronic_disease
Infection 29 38 3525 3534 I-chronic_disease

active 0 6 3535 3541 O
Central 7 14 3542 3549 B-chronic_disease
Nervous 15 22 3550 3557 I-chronic_disease
System 23 29 3558 3564 I-chronic_disease
( 30 31 3565 3566 I-chronic_disease
CNS 31 34 3566 3569 I-chronic_disease
) 34 35 3569 3570 I-chronic_disease
infection 36 45 3571 3580 I-chronic_disease

signs 0 5 3581 3586 O
of 6 8 3587 3589 O
leukoencephalopathy 9 28 3590 3609 B-chronic_disease

uncontrolled 0 12 3610 3622 O
cardiac 13 20 3623 3630 B-chronic_disease
rhythm 21 27 3631 3637 I-chronic_disease
disturbance 28 39 3638 3649 I-chronic_disease

